Experienced Healthcare Leader Laurie Smith Joins Inspirata as Vice President of Product Strategy for Clinical Trial Matching
11 Oct 2022
Tampa, Florida, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective October 3rd, 2022, Laurie Smith has joined as Vice President of Product Strategy – Clinical Trial Matching.
Laurie will be primarily focused on enhancing Inspirata’s suite of clinical trial matching solutions. This includes combining insights from her own industry experiences with feedback from the market to inform product strategy and refine market positioning.
“I look forward to collaborating with Sales, Marketing, Product Design and Software Development to ensure future product enhancements are well aligned with market requirements and solve our customers’ most pressing issues related to matching oncology patients to clinical trials,” said Laurie Smith in relation to her new role.
On top of her strong enthusiasm for applications of AI and NLP technology in clinical decision support, Laurie brings a wealth of first-hand clinical research and patient pre-screening experience. Most recently, Laurie was a Vice President for Clinical Research Services at Roswell Park Comprehensive Cancer Center. Prior to that, she had served for three decades at prominent healthcare institutions, such as AMITA Health, Rush University Medical Center, University of Chicago, Siteman Cancer Center Clinical Trials Office, and Washington University Medical Center.
“We are delighted to have someone of Laurie Smith’s caliber and experience step into this critical role,” said Satish Sanan, CEO of Inspirata. “We are confident we have found the right leader to centralize our subject matter expertise in the clinical research area, serve as an influential product evangelist, and oversee our new Advisory Board for Inspirata’s clinical trial matching solutions.”
Laurie has a Master’s degree in Management and Leadership from Webster University where she also served as an Adjunct Faculty Instructor between 1993 and 2002. At various points in time, she was a member of the Schulman Associates Institutional Review Board, Rush University Cancer Research Committee, University of Chicago Cancer Center Scientific Review Committee, Washington University Protocol Review and Monitoring Committee, CALGB CRA Core Committee, and CALGB Audit Committee.
About Inspirata
Inspirata, Inc. helps patients fighting cancer—and the clinicians they trust—to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.
Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated clinical trial matching and cancer registry solutions to bring users the broadest oncology informatics platform available globally. To learn more, visit .
Inspirata Contact:
Emil Mladenov
Vice President of Corporate and Digital Marketing
Email: emladenov@inspirata.com
Tel: +1-813-570-8914
Emil Mladenov
Inspirata, Inc.
+1-813-570-8914
emladenov@inspirata.com
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.